MMP9 and coronary stenosis: Thus, the purpose of this study was to compare the plasma NGAL, MMP-9, IL-1β, and hs-CRP levels in different clinical presentations of coronary heart disease (CHD) and to evaluate the relationship between those biomarkers and the severity of coronary stenosis in patients without kidney disease.